Carolyn M. Rucci
SVP, Chief Legal Officer · Akebia Therapeutics, Inc.
- 2026
- Feb 4, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Carolyn M. Rucci files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John P. Butler - $561K in AKBA purchases and sales in the last 12 months
- Nicholas Grund - $118K in AKBA purchases and sales in the last 12 months
- Erik Ostrowski - $111K in AKBA purchases and sales in the last 12 months
- Steven Keith Burke - $94K in AKBA purchases and sales in the last 12 months
- Richard C. Malabre - $69K in AKBA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Carolyn M. Rucci?
Carolyn M. Rucci is a corporate insider, tracked as SVP, Chief Legal Officer of Akebia Therapeutics, Inc. (AKBA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Carolyn M. Rucci last file a Form 4?
The most recent primary Form 4 on record is dated 4 February 2026, one of 2 filings going back to 2026.
Has Carolyn M. Rucci been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($97K) across all tracked filings.
